GB787607A - Toxin-inactivating substance and preparation - Google Patents

Toxin-inactivating substance and preparation

Info

Publication number
GB787607A
GB787607A GB33142/55A GB3314255A GB787607A GB 787607 A GB787607 A GB 787607A GB 33142/55 A GB33142/55 A GB 33142/55A GB 3314255 A GB3314255 A GB 3314255A GB 787607 A GB787607 A GB 787607A
Authority
GB
United Kingdom
Prior art keywords
glucose
per cent
free
culture
copper sulphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB33142/55A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Patents and Development Ltd
Original Assignee
Canadian Patents and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Patents and Development Ltd filed Critical Canadian Patents and Development Ltd
Publication of GB787607A publication Critical patent/GB787607A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

An antibiotic with an antibacterial spectrum closely related to that of penicillin is produced by the surface culture of Penicillium cyaneofulvum ATCC 11923 on a beef infusion broth containing 1 per cent glucose at 20-25 DEG C. for 7 days.ALSO:The invention relates to noxiversin which is a protein substance derived from the albumen fraction of a culture of Penicillium cyaneofulrum ATCC 11923 free of mycelium and globulin, effective in detoxifying toxins, effective as a toxoiding agent, non-dialysable, non-antibiotic, non-antigenic, non-toxic, its detoxifying and toxoiding activity not being interfered with by Clarase (penicillin inactivating substance), thermolabile, free of copper sulphate precipitated material, free of dialysable substances, its toxin inactivating activity being attributable to its capability to act directly upon the toxia molecule in contrast to a blocking action. P. cyanco fulrum is surface cultured on glucose beef infusion broth for 7 days at 20 DEG to 25 DEG C. Less suitable is a medium containing malt extract, neopeptone and glucose. The mycelium is filtered off, the pH of the culture filtrate adjusted to pH 7.0, ammonium sulphate added to 48 per cent concentration and the precipitated globulin removed by centrifugation. The clear liquid is saturated with ammonium sulphate and the active albumen fraction precipitates and is removed. This is suspended in saline and dialysed against saline for 48 hours at 5 DEG C. and negative pressure of - 6 mm. Hg. The dialysed albumen fraction may then be lyophilized and stored in ampoules at 4-10 DEG C. Alternatively, a ten-fold purification is obtained by adding 1 per cent copper sulphate to an aqueous solution of the above albumen fraction and removing the inactive precipitate which is toxic to animals. The supernatant fluid is dialysed against saline to remove excess copper sulphate. Noxiversin is thermolabile, being completely inactivated in solution after 30 minutes at 70 DEG C. It is inactivated by fresh normal serum. It is used in the preparation of toxoids and antitoxic sera for medicinal and veterinary use.
GB33142/55A 1954-11-30 1955-11-18 Toxin-inactivating substance and preparation Expired GB787607A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US787607XA 1954-11-30 1954-11-30

Publications (1)

Publication Number Publication Date
GB787607A true GB787607A (en) 1957-12-11

Family

ID=22146061

Family Applications (1)

Application Number Title Priority Date Filing Date
GB33142/55A Expired GB787607A (en) 1954-11-30 1955-11-18 Toxin-inactivating substance and preparation

Country Status (1)

Country Link
GB (1) GB787607A (en)

Similar Documents

Publication Publication Date Title
Robinson et al. Streptococcal fish pathogen
Shear et al. Chemical treatment of tumors. V. Isolation of the hemorrhage-producing fraction from Serratia marcescens (Bacillus prodigiosus) culture filtrate
ES8106407A1 (en) Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization.
US2912359A (en) Wound healing agent obtained from blood and method of preparation
Heckly et al. TOXINS OF PSEUDOMONAS PSEUDOMALLEI II: Characterization
GB787607A (en) Toxin-inactivating substance and preparation
ES309630A1 (en) Procedure for the preparation of an anticoagulant material. (Machine-translation by Google Translate, not legally binding)
Kanai et al. Alpha-hemolytic toxin of Aeromonas hydrophila produced in vivo
Boissevain Growth promotion of the tubercle bacillus by serum albumen
DUBOS THE EFFECT OF SPECIFIC AGENTS EXTRACTED FROM SOIL MICROÖRGANISMS UPON EXPERIMENTAL BACTERIAL INFECTIONS
Carne et al. The exotoxins of Corynebacterium ulcerans
GB978262A (en) Water-insoluble allergenically active substances
Tidwell et al. Use of membrane filter in blood cultures.
ATE4637T1 (en) PENTADECAPEPTIDE, PROCESS FOR ITS PREPARATION AND IMMUNSIFYING AGENT.
ES353533A1 (en) Tetanus vaccine and process for preparing it
GB1161722A (en) Improvements in or relating to the Preparation of Enzyme Solutions
GB1583006A (en) Treatment of animals with a blood volume expander
ES441849A1 (en) Treatment of bacterial cells of the species pseudomonas methylotropha or pseudomonas rosea
Hooser et al. Elimination of pleuropneumonia-like organisms from embryonic human lung tissue culture with tetracycline
Allen An investigation of the anticryptococcal properties of normal serums
Lentino et al. Delineation of the Site of Action of an Antistaphylococcal α‐Globulin
Joshi et al. Enhancing effect of proteolytic enzymes on interferon production
SE8600987L (en) PROCEDURE FOR PREPARING A PROTEIN CONCENTRATE FROM WHOLE BLOOD
SU122579A1 (en) Method of preventing inactivation of native penicillin
SU936919A1 (en) Method of treating purulent wounds